Cargando…
Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
BACKGROUND: Florbetapir (AV-45) has been shown to be a reliable tool to assess amyloid load in patients with Alzheimer's disease (AD) at demential stages. Longitudinal studies also suggest that AV-45 has the ability to bind amyloid in the early stages of AD. In this study, we investigated AV-45...
Autores principales: | Saint-Aubert, Laure, Barbeau, Emmanuel J, Péran, Patrice, Nemmi, Federico, Vervueren, Celine, Mirabel, Helene, Payoux, Pierre, Hitzel, Anne, Bonneville, Fabrice, Gramada, Raluca, Tafani, Mathieu, Vincent, Christian, Puel, Michele, Dechaumont, Sophie, Chollet, Francois, Pariente, Jeremie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733998/ https://www.ncbi.nlm.nih.gov/pubmed/23731789 http://dx.doi.org/10.1186/2191-219X-3-43 |
Ejemplares similares
-
Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo
por: Saint-Aubert, L., et al.
Publicado: (2013) -
Multimodal Magnetic Resonance Imaging in Alzheimer’s Disease Patients at Prodromal Stage
por: Eustache, Pierre, et al.
Publicado: (2016) -
Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study
por: Planton, Mélanie, et al.
Publicado: (2020) -
White matter disruption at the prodromal stage of Alzheimer's disease: Relationships with hippocampal atrophy and episodic memory performance
por: Rémy, Florence, et al.
Publicado: (2015) -
Posterior Cortical Atrophy: Does Complaint Match the Impairment? A Neuropsychological and FDG-PET Study
por: Guerrier, Laura, et al.
Publicado: (2019)